MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Pharmaceutical Economics and Policy
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,682 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,682 works in the cohort · of 4,299,418page 5 of 34

Labels cover 5 of 1,682 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,682 of 1,682 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

venueaboutno affunlabeled
Drug coverage in Canada: gaps and opportunities
Fiona Clement, Katherine A. Memedovich
2018· editorial· en· Journal of Psychiatry and Neuroscience· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
26
citations
afffundvenueaboutunlabeled
Delays in the submission of new drugs in Canada
Ali Shajarizadeh, Aidan Hollis
2014· review· en· Canadian Medical Association Journal· Economics, Econometrics and Finance
distilled prediction:candidate · insufficient_payloadconsensus · none
24
citations
aboutno affunlabeled
Selegiline shortage
E. Ray Dorsey, J. P. Thompson, Elias J. Dayoub, Benjamin P. George, L. A. Saubermann, Robert G. Holloway
2009· article· en· Neurology· Economics, Econometrics and Finance
distilled prediction:candidate · insufficient_payloadconsensus · none
24
citations
affunlabeled
The Opportunity Cost of Capital
Ayman Chit, Ahmad Chit, M. Papadimitropoulos, Murray Krahn, Jayson L. Parker, Paul Grootendorst
2015· article· en· INQUIRY The Journal of Health Care Organization Provision and Financing· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
23
citations
affunlabeled
When Choosing Statin Therapy
Jonas B. Green, Joseph S. Ross, Cynthia A. Jackevicius, Nilay D. Shah, Harlan M. Krumholz
2013· review· en· JAMA Internal Medicine· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
23
citations
affunlabeled
WHO Model list of essential medicines: visions for the future
Thomas Piggott, Lorenzo Moja, Benedikt Huttner, Patrick Okwen, Mario Raviǵlione, Tamara Kredo +1 more
2024· article· en· Bulletin of the World Health Organization· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
23
citations
aboutno affunlabeled
Why healthcare market needs government intervention to improve access to essential medicines and healthcare efficiency: a scoping review from pharmaceutical price regulation perspective
Mende Mensa Sorato, Majid Davari, Akbar Abdollahi Asl, Fatemeh Soleymani, Abbas Kebriaeezadeh
2020· review· en· Journal of Pharmaceutical Health Services Research· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · none
22
citations
affaboutunlabeled
Differences in Drug Shortages in the US and Canada
Mina Tadrous, Katherine Callaway Kim, Inmaculada Hernandez, Scott D. Rothenberger, Joshua W. Devine, Tina Batra Hershey +3 more
2024· article· en· JAMA· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
22
citations
affno abstractunlabeled
Developing Novel Drugs
Joshua Krieger, Danielle Li, Dimitris Papanikolaou
2017· article· en· SSRN Electronic Journal· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
22
citations
afffundunlabeled
Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health
Catherine Olivier, Bryn Williams–Jones, Béatrice Godard, Barbara Mikalson, Vural Özdemir
2008· article· en· Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+sts+research_integrityconsensus · none
21
citations
affno abstractunlabeled
The black market in prescription drugs
Stefan Grzybowski
2004· article· en· The Lancet· Economics, Econometrics and Finance
distilled prediction:candidate · insufficient_payloadconsensus · none
21
citations
fundno affunlabeled
Improving access to insulin: what can be done?
David Beran
2011· article· en· Diabetes Management· Economics, Econometrics and Finance
distilled prediction:candidate · insufficient_payloadconsensus · none
21
citations
affunlabeled
Preferred Pharmacy Networks and Drug Costs
Amanda Starc, Ashley Swanson
2021· article· en· American Economic Journal Economic Policy· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
21
citations

How this was built: Screen · Findings · About